We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
1Author, Samarth institute of pharmacy, Belhe, Maharashtra, India.
2Co-Author, Samarth institute of pharmacy, Belhe, Maharashtra, India.
3Samarth institute of pharmacy, Belhe, Maharashtra, India.
Over the past 20 years, dragon fruit—which comes from cactus species in the genera Hylocereus and Selenicereus—has attracted a lot of scientific attention due to its unique phytochemical makeup and variety of biological activity. With an emphasis on their developing uses in pharmaceutical and cosmetic formulations, this review thoroughly assesses the phytochemical components, pharmacological characteristics, and extraction techniques of dragon fruit extracts. A variety of bioactivities, including as antioxidant, anti-inflammatory, antibacterial, anti-aging, skin-brightening, and wound-healing benefits, are attributed to the abundance of betacyanins (particularly betanin and isobetanin), flavonoids, polyphenols, vitamins C and E, and dietary fiber found in dragon fruit. In cosmetics, dragon fruit extracts have demonstrated significant potential as functional ingredients in moisturizers, sunscreens, anti-aging serums, and hair care products. In pharmaceutical applications, their bioactive compounds show promise for managing oxidative stress-related diseases, skin disorders, metabolic conditions, and as adjuvants in drug delivery systems. This review critically assesses the scientific evidence, formulation challenges, stability considerations, regulatory aspects, and future research directions necessary for mainstreaming dragon fruit extracts in modern cosmeceutical and pharmaceutical markets.
Dragon fruit, sometimes called pitaya or pitahaya, is a member of the Cactaceae family and is mostly grown from three species: Selenicereus megalanthus (white-fleshed with yellow skin), Hylocereus undatus (white-fleshed with red skin), and Hylocereus polyrhizus (red-fleshed with red skin). Originally from Central and South America, it has grown to be a major crop in Asia, especially in Vietnam, Thailand, China, Indonesia, and Malaysia. Although it has gained popularity as a functional food due to its eye-catching look, sweet flavor, and plenty of nutrients, growing scientific study has shown that it has significant promise as a bioactive ingredient in the pharmaceutical and cosmetic industries.The desire from consumers for natural, sustainable, and effective ingredients has caused a significant change in the worldwide cosmeceutical market toward bioactives derived from plants. Dragon fruit is a perfect fit for this trend because of its diverse phytochemical profile, which provides multifunctional biological activities related to systemic health, wound care, and skin care. The variety of potential uses is increased by the unique compositions of bioactive compounds found in the plant's flesh, peel, seeds, and flowers. A comprehensive, systematic assessment of dragon fruit's use in pharmaceutical and cosmetic formulations is still lacking, despite an increasing amount of research on the fruit's nutritional and therapeutic qualities. By summarizing existing information on the following topics, this review seeks to close that gap: (i) phytochemical composition and extraction methods; (ii) pharmacological activities of important constituents; (iii) cosmetic applications and formulation design; (iv) pharmaceutical uses and drug delivery considerations; (v) safety and regulatory frameworks; and (vi) future research directions.
2. Taxonomy and Botanical Description-
There are about eighteen species in the genus Hylocereus, all of which are classified as lithophytic or epiphytic cacti with huge, nocturnal blooms and triangular, succulent stems. Hylocereus undatus is now occasionally reclassified as Selenicereus undatus in more current taxonomic systems due to changes in the taxonomy. Key botanical characteristics and the geographic range of the main commercial species are shown in Table 1.
Table 1: Botanical Classification and Key Characteristics of Commercial Dragon Fruit Species
|
Species |
Common Name |
Flesh Color |
Skin Color |
Key Bioactives |
Primary Region |
|
H. undatus |
White pitaya |
White |
Red/Pink |
Betacyanins (low), Vitamin C |
Southeast Asia, Americas |
|
H. polyrhizus |
Red pitaya |
Red/Purple |
Red/Pink |
Betacyanins (high), Lycopene |
Malaysia, Vietnam |
|
S. megalanthus |
Yellow pitaya |
White |
Yellow |
Flavonoids, Vitamin C |
Colombia, Israel |
|
H. costaricensis |
Costa Rica pitaya |
Red/Purple |
Red |
Betacyanins, Polyphenols |
Central America |
The plant is an economically appealing crop due to its exceptional capacity to adapt to tropical and subtropical temperatures, as well as its quick growth and high yield. Every component of the dragon fruit plant, including the peel, pulp, seeds, stems, and flowers, has unique bioactive profiles that open up new possibilities for use in medicine and cosmetics.
3. Phytochemical Composition
3.1 Betacyanins and Betalains
The main pigments that give red-fleshed dragon fruit types their striking reddish-violet hue are betacyanins. In addition to trace levels of hylocerenin and bougainvillein, the most common betacyanins found include betanin (betanidin 5-O-glucoside), isobetanin, phyllocactin, and isophyllocactin. Only species of the order Caryophyllales contain these water-soluble nitrogen-containing pigments, which are members of the larger betalain class. The quantities of betacyanins from H. polyrhizus have been reported to range from 32 to 62 mg per 100 g fresh weight of peel, with relatively smaller amounts found in the flesh. High antioxidant capacity is conferred by the structural characteristics of betacyanins, especially the conjugated chromophore system and the hydroxyl and carboxyl groups. Depending on extraction conditions, betanin's IC50 values for DPPH radical scavenging activity range from 1.8 to 5.6 mg/mL. Their stability is extremely sensitive to heat, light, and oxygen and highly pH-dependent (ideal at pH 4–5), which creates formulation issues that are covered in following sections.
3.2 Phenolic Compounds and Flavonoids
A wide range of phenolic chemicals can be found in dragon fruit, such as flavonoids (quercetin, kaempferol, isorhamnetin, rutin), hydroxybenzoic acids (gallic acid, protocatechuic acid), and hydroxycinnamic acids (ferulic acid, caffeic acid, p-coumaric acid). Dragon fruit peel has a total phenolic content (TPC) of 6.2–22.4 mg gallic acid equivalents (GAE)/g dry weight, whereas the pulp usually has a TPC of 2.8–9.1 mg GAE/g dry weight. The peel is a valuable by-product for use in nutraceutical and cosmetic applications since it constantly exhibits higher phenolic content than the pulp.
3.3 Vitamins and Mineral Profile
Dragon fruit is very rich in vitamin C (ascorbic acid), with values of 20–25 mg/100 g fresh weight reported for white-fleshed types and somewhat lower amounts in red variations. Tocopherols, or vitamin E, are mostly found in seeds (~0.2–0.5 mg/100 g). Thiamine (B1), riboflavin (B2), and niacin (B3) are examples of B-vitamins that support metabolic activity. Minerals that have been identified include potassium, calcium, phosphorus, magnesium, trace iron, and zinc. Dragon fruit extracts' antioxidant and skin-conditioning qualities are enhanced by these micronutrients working in concert.
3.4 Other Bioactive Constituents
By oil weight, dragon fruit seeds have between 42 and 50 percent fatty acids, with linoleic acid (omega-6, ~42%), oleic acid (~22%), and palmitic acid (~17%) being the most common. This lipid profile promotes moisturization and the function of the epidermal barrier. Pectin-type dietary fiber, which has prebiotic, film-forming, and moisturizing qualities, makes up 5–13% of the peel's dry weight. Red variants are rich in lycopene, a carotenoid antioxidant with proven photoprotective and anti-carcinogenic properties.
Table 2: Summary of Major Phytochemical Classes in Dragon Fruit and Their Bioactivities
|
Phytochemical Class |
Major Compounds |
Primary Source |
Reported Concentration |
Key Activity |
|
Betacyanins |
Betanin, Isobetanin, Phyllocactin |
Peel > Pulp |
32–62 mg/100 g FW (peel) |
Antioxidant, anti-inflammatory |
|
Phenolic acids |
Gallic, Ferulic, Caffeic acid |
Peel, Pulp |
6.2–22.4 mg GAE/g DW |
Antioxidant, antimicrobial |
|
Flavonoids |
Quercetin, Kaempferol, Rutin |
Peel, Pulp |
1.5–8.2 mg QE/g DW |
Anti-inflammatory, anti-aging |
|
Vitamins |
Ascorbic acid, Tocopherols |
Pulp, Seeds |
20–25 mg/100 g FW |
Antioxidant, collagen synthesis |
|
Fatty acids |
Linoleic, Oleic, Palmitic acid |
Seeds |
42–50% of seed oil |
Emollient, barrier function |
|
Carotenoids |
Lycopene, Beta-carotene |
Pulp (red varieties) |
0.3–1.2 mg/100 g FW |
Photoprotective, antioxidant |
|
Fiber/Pectin |
Galacturonic acid units |
Peel |
5–13% DW |
Film-forming, moisturizing |
4. Extraction Methodologies
4.1 Conventional Extraction Techniques
For dragon fruit phytochemicals, the most popular conventional techniques are maceration, Soxhlet extraction, and aqueous-ethanolic extraction. Polyphenols and betacyanins are efficiently recovered by maceration (50–70% ethanol, 24–72 hours at room temperature) with little heat degradation. For nonpolar components and seed oil, soxhlet extraction works well; however, it is not appropriate for thermolabile betacyanins. Pectin is frequently extracted from dragon fruit peels using water at temperatures between 40 and 60 degrees Celsius.
4.2 Advanced and Green Extraction Techniques
By using acoustic cavitation, Ultrasound-Assisted Extraction (UAE) greatly improves the extraction efficiency of betacyanins and phenolics, cutting down on solvent consumption and extraction time to 10–30 minutes while improving yields by 15–30% when compared to maceration. Although Microwave-Assisted Extraction (MAE) provides great extraction efficiency and quick extraction (5–15 min), it necessitates careful temperature management to avoid betacyanin degradation above 50°C. Dragon fruit seed oil is especially well-suited for Supercritical Fluid Extraction (SFE) utilizing CO2, with or without polar co-solvents like ethanol, which produces high-purity extracts devoid of solvent residue—a crucial factor for raw materials used in cosmetics and pharmaceuticals. Enzyme-Assisted Extraction (EAE) produces extracts with improved antioxidant capacity by breaking down cell walls with cellulases, pectinases, and proteases. It has been shown that High-Pressure Processing (HPP) at 200–600 MPa for 1–10 minutes increases betacyanin production and maintains bioactivity without thermal degradation. High recovery rates can be achieved in 10–20 minutes with Pressurized Liquid Extraction (PLE/ASE), which allows for quick extraction at high temperatures and pressures.
5. Pharmacological Activities of Dragon Fruit Extracts
5.1 Antioxidant Activity
Dragon fruit extracts' antioxidant potential has been thoroughly studied utilizing DPPH, ABTS, FRAP, and ORAC assays. Because of their higher betacyanin and lycopene content, red-fleshed varieties (H. polyrhizus) regularly show better antioxidant activity (DPPH IC50: 1.2–4.8 mg/mL) than white-fleshed types (DPPH IC50: 4.2–12.6 mg/mL). All types of peel extracts are more potent antioxidants than pulp extracts. The overall ability to scavenge radicals is enhanced by the synergistic interplay of phenolics, vitamin C, and betacyanins. Dragon fruit peel extract at 50–200 µg/mL dramatically decreased intracellular reactive oxygen species (ROS) in H2O2-challenged keratinocytes in cellular models without causing cytotoxicity.
5.2 Anti-inflammatory Activity
Through a variety of ways, extracts from dragon fruit suppress important inflammatory mediators. By inhibiting NF-κB activation, phenolic substances (quercetin, kaempferol) lower the production of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). These pathways facilitate the use of formulations that treat inflammatory skin disorders such psoriasis, rosacea, acne vulgaris, and atopic dermatitis.
5.3 Antimicrobial Activity
Extracts from dragon fruit pulp and peel show broad-spectrum antibacterial action. Ethanolic peel extract has a minimum inhibitory concentration (MIC) of 3.12 to 12.5 mg/mL against Staphylococcus aureus, 6.25 to 25 mg/mL against Escherichia coli, and 6.25 to 50 mg/mL against Candida albicans. Phenolic acids and flavonoids, which compromise the integrity of microbial membranes and impede enzymatic activities, are mainly responsible for the antibacterial activity. Peel extracts are useful for acne treatment formulations since they have demonstrated inhibitory efficacy against Propionibacterium acnes (MIC: 1.56–6.25 mg/mL).
5.4 Anti-aging and Skin-Brightening Effects
Extracts from dragon fruit alter a number of targets related to aging skin. In UV-irradiated fibroblasts, betanin and phenolic fractions inhibit matrix metalloproteinase-1 (MMP-1) and MMP-3, decreasing collagen breakdown. By serving as an enzymatic cofactor for prolyl and lysyl hydroxylases, vitamin C concentration encourages the production of collagen. In photoprotection, ferulic acid works in concert with vitamins C and E to improve their UV stability and effectiveness. Gallic acid and other flavonoids from dragon fruit extracts inhibit kojic acid-like tyrosinase (IC50: 12–35 µg/mL), which helps skin-brightening treatments for hyperpigmentation.
5.5 Wound Healing Activity
Formulations containing dragon fruit peel extract show faster wound closure in both in vivo excision wound models and in vitro scratch assays. Increased collagen deposition, improved fibroblast migration and proliferation, and anti-inflammatory actions are all part of the wound-healing pathways. In comparison to controls, a 5% (w/w) peel extract gel considerably accelerated wound closure in Sprague-Dawley rats by day 14 (97.2% vs. 72.4% wound contraction). Additionally, dragon fruit peel pectin forms a hydrogel film that creates a moist healing environment and physical framework for cellular regeneration.
5.6 Photoprotective Activity
In vitro SPF values are influenced by UV-absorbing substances found in dragon fruit extracts, including as flavonoids, which absorb light at 300–350 nm, and betacyanins, which absorb light at 536 nm. According to studies, adding 2–5% w/w of dragon fruit peel extract to emulsion formulations raises SPF values by 3–8 units when compared to base formulations. Additionally, singlet oxygen produced by UVA exposure is quenched by lycopene and beta-carotene. Dragon fruit extracts are multifunctional photoprotective substances because they combine UV absorption with antioxidant neutralization of UV-induced free radicals.
6. Cosmetic and Cosmeceutical Applications
6.1 Anti-aging Formulations
The use of dragon fruit extracts in anti-aging serums, lotions, and masks that target several aging processes at once is growing. MMP inhibition (collagen preservation), antioxidant defense against oxidative aging, and moisture improvement via peel-derived pectin and seed oil emollients are important processes. In clinical pilot investigations, formulations containing 3–5% dragon fruit peel extract and hyaluronic acid have shown statistically significant increases in skin elasticity (up to 18% improvement by cutometry) and reduction of fine lines (up to 12% decrease evaluated by optical profilometry).
6.2 Moisturizing and Skin-Conditioning Products
Rich in linoleic acid, cold-pressed dragon fruit seed oil effectively penetrates the stratum corneum and reinstates skin barrier function. By restoring the intercellular lipid matrix, linoleic acid specifically treats ceramide insufficiency in dry and atopic skin. Seed oil considerably raises skin hydration scores and transepidermal water loss (TEWL) at doses of 2–5% in formulations. When added to hydrogels and lotions, the mucilaginous polysaccharides from dragon fruit peel show film-forming moisturizing activity, providing an occlusive layer that lowers TEWL.
6.3 Skin Brightening and Pigmentation Management
Dragon fruit extracts are formulated in brightening serums and spot treatments targeting tyrosinase-mediated melanogenesis. Gallic acid and quercetin, acting as tyrosinase inhibitors, reduce melanin synthesis in B16 melanoma cell models without cellular toxicity at effective concentrations. Formulations containing 2% dragon fruit extract showed a significant reduction in melanin index (measured by Mexameter MX18) comparable to 1% kojic acid in a 12-week pilot clinical study. The Vitamin C content additionally functions as a melanin oxidation inhibitor, providing dual-action brightening.
6.4 Sunscreen Formulations
The UV-absorbing properties of dragon fruit betacyanins, flavonoids, and carotenoids make them attractive as natural SPF-boosting ingredients. Multilamellar liposomal encapsulation of dragon fruit peel extract at 3–5% concentration improves photostability and enhances SPF contribution. Studies demonstrate synergistic photoprotection when dragon fruit extracts are combined with synthetic UV filters (oxybenzone, avobenzone), potentially enabling reduced concentrations of synthetic filters and improving the safety profile of sunscreen formulations. The photoquenching activity of lycopene against UVA-induced singlet oxygen provides additional photoprotective value.
6.5 Hair Care Applications
Dragon fruit extracts show promise for hair care through a variety of mechanisms: antimicrobial activity relevant to dandruff management (Malassezia furfur inhibition); anti-inflammatory effects on the scalp; conditioning benefits from seed oil fatty acids; and antioxidant protection of hair proteins (keratins) against oxidative damage from UV, pollution, and chemical treatments. On bleached and grey hair substrates, betacyanins have been studied as natural hair colorants that provide rose-violet tones with moderate wash fastness (5–8 wash cycles). In mechanical tests, peel extract at 1-3% in shampoo formulations significantly increases the tensile strength of chemically damaged hair.
Table 3: Summary of Cosmetic and Cosmeceutical Applications of Dragon Fruit Extracts
|
Application Type |
Active Components |
Concentration Used |
Key Benefit |
Formulation Format |
|
Anti-aging cream |
Peel polyphenols, Seed oil |
3–5% peel extract, 2–4% seed oil |
MMP inhibition, collagen support |
O/W emulsion, serum |
|
Moisturizer |
Seed oil, Peel pectin |
2–5% seed oil |
Barrier restoration, hydration |
Lotion, cream, gel |
|
Skin brightening |
Gallic acid, Quercetin, Vitamin C |
2–3% extract |
Tyrosinase inhibition |
Serum, spot treatment |
|
Sunscreen |
Betacyanins, Flavonoids, Lycopene |
3–5% extract |
SPF enhancement, photoprotection |
Emulsion, gel |
|
Hair care |
Seed oil, Peel phenolics |
1–3% extract, 1–2% oil |
Conditioning, anti-dandruff |
Shampoo, conditioner |
|
Wound care mask |
Peel polysaccharides, Phenolics |
5–10% peel extract |
Wound healing, anti-inflammatory |
Hydrogel, mask sheet |
|
Acne treatment |
Phenolic acids, Betacyanins |
1–4% extract |
Antimicrobial, anti-inflammatory |
Gel, serum |
7. Pharmaceutical Applications
7.1 Management of Oxidative Stress-Related Diseases
Dragon fruit extracts' strong antioxidant potential has been studied in relation to oxidative stress-mediated conditions such as type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and neurological disorders.
7.2 Dermatological and Wound Management
In preclinical models, topical pharmaceutical formulations using dragon fruit peel extract (5–10% w/w) in carbopol hydrogels and chitosan-based films have shown improved wound healing results. A synergistic environment for wound healing is produced by the anti-inflammatory, antibacterial, and collagen-stimulating qualities.
7.3 Drug Delivery Systems
Materials obtained from dragon fruit have several options for the delivery of pharmacological drugs. Because dragon fruit peel pectin is susceptible to enzymatic degradation by colonic bacteria (pectinases), it has been thoroughly studied as an excipient for colon-targeted medication delivery systems. Curcumin and betanin have been combined to create solid lipid nanoparticles that exhibit improved cellular absorption and synergistic antioxidant effects.
7.4 Anti-cancer Potential
Dragon fruit extracts have been shown to be cytotoxic to cancer cell lines in a number of in vitro investigations. According to annexin V staining and caspase-3/7 activation, ethanolic peel extract demonstrated IC50 values of 80–150 µg/mL against HeLa (cervical), MCF-7 (breast), and HepG2 (hepatocellular) cell lines via apoptosis induction. The processes include cell cycle arrest at the G2/M phase and mitochondrial dysfunction caused by ROS. It is important to remember that these are preliminary in vitro results, and there is still a lack of in vivo pharmacokinetics, bioavailability, and efficacy data, which calls for additional study before clinical translation.
8. Formulation Challenges and Stability Considerations
8.1 Betacyanin Stability
The main formulation problem with dragon fruit extracts is the intrinsic instability of betacyanins, which can be broken down by heat (>50°C), light (particularly UV), oxygen, and pH extremes. Without precautions, betanin's half-life in aqueous solution at pH 7 and 40°C is roughly 6–12 hours. The following are examples of stabilization techniques: (i) pH optimization to 4.0–5.0 using ascorbic acid or citric acid buffers; (ii) encapsulation in microparticles (maltodextrin, arabic gum, cyclodextrin inclusion complexes); (iii) addition of antioxidant co-stabilizers (ascorbic acid, EDTA); (iv) nitrogen gas blanketing during manufacturing; and (v) light-protective opaque packaging.
8.2 Encapsulation Technologies
Microencapsulation and nanoencapsulation have become essential methods for enhancing the stability and controlled release of betacyanin. Encapsulation efficiencies of 75–90% are achieved and shelf life is greatly increased by spray-drying maltodextrin and gum arabic as wall materials at 10:1 to 20:1 ratios. Liposomal encapsulation offers a sustained-release profile and enhances polyphenol skin penetration. The simultaneous delivery of lipophilic and hydrophilic bioactives while improving photostability is made possible by solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) that use dragon fruit seed oil as the lipid phase. Thermal stability is increased by around two times when betanin is complexed with cyclodextrin.
8.3 Standardization Challenges
The composition of dragon fruit extract varies from batch to batch, which poses a serious problem for quality control. Variety, cultivation location, seasonal variables, ripening stage, post-harvest processing, and drying techniques all affect phytochemical profiles. For commercial extracts, standardization to a certain betacyanin level (e.g., 10% betanin by HPLC) or total polyphenol content is advised. For routine quality control, validated analytical techniques such as spectrophotometric techniques (TPC, TFC, DPPH), HPLC-DAD (for betacyanins), and HPLC-MS (for phenolic profiling) should be used.
9. Safety, Toxicology, and Regulatory Considerations
9.1 Safety Profile
Dragon fruit has a long history of being consumed by humans without any negative consequences, making it generally regarded as safe (GRAS). Aqueous and ethanolic peel extracts had LD50 values greater than 5,000 mg/kg body weight in mouse acute oral toxicity trials, indicating that they are essentially non-toxic. The main pigment, betanin, exhibits no genotoxicity in the Comet assay and no mutagenicity in Ames assays at quantities up to 1,000 µg/mL. Peel extract compositions' dermal safety evaluations show no possibility for sensitization in Buehler and maximization testing in guinea pigs. Nevertheless, there is still a dearth of information about phototoxicity and repeated-dose skin toxicity for standardized extracts.
9.2 Regulatory Landscape
Each jurisdiction has a different regulatory classification for extracts from dragon fruit. Hylocereus undatus fruit extract serves as an antioxidant and skin conditioner and is listed in the CosIng database (Cosmetic Ingredient) in the European Union. Dragon fruit is approved by the US FDA as a food ingredient, and its usage in cosmetics is governed by the FDA's voluntary cosmetic registration program (VCRP). The EU and Codex Alimentarius have authorized betanin (E 162) as a natural food coloring. Extracts meant to be used as active pharmaceutical ingredients (APIs) in pharmaceutical applications must meet GMP standards, pharmacopoeia monograph specifications (if applicable), and clinical trials that demonstrate safety and efficacy under applicable IND/CTA frameworks.
10. Future Research Directions
There are many interesting directions for further research in the area of dragon fruit extract applications in pharmaceuticals and cosmetics:
• Clinical validation: To support the in vitro and preclinical efficacy results in human patients, well-designed, randomized controlled clinical trials are essential, especially for anti-aging, skin brightening, wound healing, and antidiabetic applications.
• Bioavailability enhancement: methodical development of nanoformulation techniques (NLCs, polymeric nanoparticles, lipid-polymer hybrid nanoparticles) to get around transdermal penetration barriers for polyphenols and low oral bioavailability of betacyanins.
• Metabolomics-guided standardization: To create strong standardization frameworks connected to bioactivity results, extracts from various cultivars, growth environments, and processing techniques are thoroughly metabolomically profiled. • Sustainable extraction and valorization: By optimizing green extraction techniques, dragon fruit peel is used as a by-product of food processing, supporting sustainability and the circular economy.• Microbiome interactions: Research on how polysaccharides from dragon fruit peels affect the gut and skin microbiome, which may have systemic anti-inflammatory and metabolic effects.
• Development of drug delivery excipients: Additional analysis of dragon fruit pectin and polysaccharides as excipients in topical, mucoadhesive, and colon-targeted delivery systems.
• Cosmetic stability acceleration studies: To determine commercial shelf life, encapsulated dragon fruit extract formulations are subjected to systematic accelerated stability testing (40°C/75% RH, photostability per ICH Q1B).
• Combination synergies: Investigating how dragon fruit bioactives can work in concert with other well-known cosmeceutical ingredients (retinoids, niacinamide, hyaluronic acid) to improve anti-aging regimen efficacy.
CONCLUSION
Extracts from dragon fruit (Hylocereus spp.) are an economically significant and scientifically compelling source of bioactive chemicals for use in medicinal and cosmetic applications. A complex biological activity profile with strong antioxidant, anti-inflammatory, antimicrobial, anti-aging, wound-healing, and photoprotective qualities is imparted by the rich phytochemical matrix, which is made up of betacyanins, polyphenols, flavonoids, vitamins, essential fatty acids, and polysaccharides. While pharmaceutical uses include wound care, oxidative stress-related illness management, medication delivery, and growing anti-cancer research, cosmeceutical applications include anti-aging formulations, moisturizers, skin brightening products, sunscreens, and hair care. Before full commercial mainstreaming, despite encouraging data, a number of issues need to be methodically resolved. These include managing betacyanin stability through encapsulation and formulation strategies, establishing batch-to-batch standardization frameworks, and strengthening clinical evidence through rigorous human trials. Dragon fruit peel is widely available as an agricultural by-product, which further emphasizes the sustainability and economic justification for its industrial utilization. Dragon fruit extracts are well-positioned to move from a promising research topic to established formulation ingredients as consumer preferences continue to shift toward nature-derived, multipurpose cosmeceutical ingredients and as the pharmaceutical industry increasingly investigates phytogenic actives and excipients. To fully achieve this potential, interdisciplinary research linking phytochemistry, formulation science, clinical pharmacology, and regulatory science must continue.
REFERENCES
Bhor Neha*, Wakale Megha, Barhate Chaitali, Ingale Akshata, Datkhile Sachin, Evaluation of Dragon Fruit (Hylocereus) Extracts in Cosmetic and Pharmaceutical Applications: A Comprehensive Review, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 7294-7304. https://doi.org/10.5281/zenodo.20410447
10.5281/zenodo.20410447